Comparison of the cytotoxicity of amsacrine and its analogue CI-921 against cultured human and mouse bone marrow tumour cells

This publication has 24 references indexed in Scilit:

• The clinical pharmacokinetics of N-5-dimethyl-9-[(2-methoxy-4-methyl-sulfonylamino)phenylamino]-4-acridinecarboxamide (CI-921) in a phase 1 trial
  Cancer Chemotherapy and Pharmacology, 1988
• Derivatives of Amsacrine: Determinants Required for High Activity Against Lewis Lung Carcinoma
  JNCI Journal of the National Cancer Institute, 1988
• Mechanism of resistance of non-cycling mammalian cells to 4′-[9-acridinylamino]methanesulphon-m-anisidide: Role of DNA topoisomerase II in log- and plateau-phase CHO cells
  Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1988
• Comparison of in Vitro activity of cytotoxic drugs towards human carcinoma and leukaemia cell lines
  European Journal of Cancer and Clinical Oncology, 1986
• The use of human cancer cell lines as a primary screening system for antineoplastic compounds
  European Journal of Cancer and Clinical Oncology, 1984
• Differential growth inhibition of cultured mammalian cells: Comparison of clinical antitumour agents and amsacrine derivatives
  European Journal of Cancer and Clinical Oncology, 1984
• Myelo-lymphopoietic stem cells in human bone marrow
  Annals of Hematology, 1982
• Treatment of acute myeloid leukaemia with a triple cytotoxic regime: dat
  British Journal of Cancer, 1977
• The experimental antitumour properties of three congeners of the acridylmethanesulphonanilide (AMSA) series
  Published by Elsevier ,1974
• Cytological Identification of Radiation-Chimæras
  Nature, 1956